BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9152248)

  • 1. Local inhibition of natural killer cell activity promotes the progressive growth of intraocular tumors.
    Apte RS; Mayhew E; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1997 May; 38(6):1277-82. PubMed ID: 9152248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between natural killer cell susceptibility and metastasis of human uveal melanoma cells in a murine model.
    Ma D; Luyten GP; Luider TM; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):435-41. PubMed ID: 7843912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of natural killer cells on engraftment of human lymphoid cells and on metastasis of human T-lymphoblastoid leukemia cells in C57BL/6J-scid mice and in C57BL/6J-scid bg mice.
    Christianson SW; Greiner DL; Schweitzer IB; Gott B; Beamer GL; Schweitzer PA; Hesselton RM; Shultz LD
    Cell Immunol; 1996 Aug; 171(2):186-99. PubMed ID: 8806787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo effects of anti-asialo GM1. I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice.
    Habu S; Fukui H; Shimamura K; Kasai M; Nagai Y; Okumura K; Tamaoki N
    J Immunol; 1981 Jul; 127(1):34-8. PubMed ID: 7240748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Destructive and nondestructive patterns of immune rejection of syngeneic intraocular tumors.
    Knisely TL; Luckenbach MW; Fischer BJ; Niederkorn JY
    J Immunol; 1987 Jun; 138(12):4515-23. PubMed ID: 3108394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of human natural killer cells on the metastatic growth of human melanoma xenografts in mice with severe combined immunodeficiency.
    Hill LL; Perussia B; McCue PA; Korngold R
    Cancer Res; 1994 Feb; 54(3):763-70. PubMed ID: 8306339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in NK cell-mediated and IFN-gamma-dependent suppression of subcutaneous tumor growth.
    Takeda K; Smyth MJ; Cretney E; Hayakawa Y; Yamaguchi N; Yagita H; Okumura K
    Cell Immunol; 2001 Dec; 214(2):194-200. PubMed ID: 12088418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antileukemia activity of a natural killer cell line against human leukemias.
    Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
    Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of correlation between natural killer activity and tumor growth control in nude mice with different immune defects.
    Fodstad O; Hansen CT; Cannon GB; Statham CN; Lichtenstein GR; Boyd MR
    Cancer Res; 1984 Oct; 44(10):4403-8. PubMed ID: 6467201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterization of a unique natural killer cell inhibitory factor present in the anterior chamber of the eye.
    Apte RS; Niederkorn JY
    J Immunol; 1996 Apr; 156(8):2667-73. PubMed ID: 8609381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flt-3 ligand inhibits growth of human ovarian tumors engrafted in severe combined immunodeficient mice.
    Silver DF; Hempling RE; Piver MS; Repasky EA
    Gynecol Oncol; 2000 Jun; 77(3):377-82. PubMed ID: 10831345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophils contribute to the biological antitumor activity of rituximab in a non-Hodgkin's lymphoma severe combined immunodeficiency mouse model.
    Hernandez-Ilizaliturri FJ; Jupudy V; Ostberg J; Oflazoglu E; Huberman A; Repasky E; Czuczman MS
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5866-73. PubMed ID: 14676108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer cell-dependent suppression of systemic spread of human lung adenocarcinoma cells by monocyte chemoattractant protein-1 gene transfection in severe combined immunodeficient mice.
    Nokihara H; Yanagawa H; Nishioka Y; Yano S; Mukaida N; Matsushima K; Sone S
    Cancer Res; 2000 Dec; 60(24):7002-7. PubMed ID: 11156403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined immunogene therapy of IL-6 and IL-15 enhances anti-tumor activity through augmented NK cytotoxicity.
    Lin CY; Chuang TF; Liao KW; Huang YJ; Pai CC; Chu RM
    Cancer Lett; 2008 Dec; 272(2):285-95. PubMed ID: 18760876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor cell apoptosis, lymphocyte recruitment and tumor vascular changes are induced by low temperature, long duration (fever-like) whole body hyperthermia.
    Burd R; Dziedzic TS; Xu Y; Caligiuri MA; Subjeck JR; Repasky EA
    J Cell Physiol; 1998 Oct; 177(1):137-47. PubMed ID: 9731754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tumorigenicity of IL-2 gene-transfected murine M-3D melanoma cells is determined by the magnitude and quality of the host defense reaction: NK cells play a major role.
    Schneeberger A; Koszik F; Schmidt W; Kutil R; Stingl G
    J Immunol; 1999 Jun; 162(11):6650-7. PubMed ID: 10352282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of the glucocorticoid response during Ad5IL-12 adenovirus vector treatment enhances natural killer cell-mediated killing of MHC class I-negative LNCaP prostate tumors.
    Raja Gabaglia C; Diaz de Durana Y; Graham FL; Gauldie J; Sercarz EE; Braciak TA
    Cancer Res; 2007 Mar; 67(5):2290-7. PubMed ID: 17332360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An oligosaccharide biosynthetic defect in concanavalin A-resistant Chinese hamster ovary (CHO) cells that enhances NK reactivity in vitro and in vivo.
    Pohajdak B; Wright JA; Greenberg AJ
    J Immunol; 1984 Nov; 133(5):2423-9. PubMed ID: 6481160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-NK antibodies injected into recipient mice enhance engraftment and chimerism after allogeneic transplantation of fetal liver stem cells.
    Chargui J; Moya MJ; Sanhadji K; Blanc-Brunat N; Touraine JL
    Thymus; 1997; 24(4):233-46. PubMed ID: 9493286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo characteristics of human squamous cell carcinoma of the head and neck cells engineered to secrete interleukin-2.
    Nagashima S; Reichert TE; Kashii Y; Suminami Y; Chikamatsu K; Whiteside TL
    Cancer Gene Ther; 1997; 4(6):366-76. PubMed ID: 9408607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.